These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26849008)

  • 1. The cut-off value for interleukin 34 as an additional potential inflammatory biomarker for the prediction of the risk of diabetic complications.
    Zorena K; Jachimowicz-Duda O; Wąż P
    Biomarkers; 2016; 21(3):276-82. PubMed ID: 26849008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-19 and angiopoietin-2 can enhance angiogenesis of diabetic complications.
    Li L; Yu ZH; Qian L; Xu JY; Liu F; Zhao GC; Zhang L; Gu HM; Zhang SJ; Meng J
    J Diabetes Complications; 2016 Mar; 30(2):386-7. PubMed ID: 26657726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of interleukin-6 (Il-6), interleukin-18 (Il-18) and C-reactive protein (CRP) in patients with type-2 diabetes and acute coronary syndrome without ST-segment elevation.
    Souza JR; Oliveira RT; Blotta MH; Coelho OR
    Arq Bras Cardiol; 2008 Feb; 90(2):86-90. PubMed ID: 18392379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein as a marker of progression of carotid atherosclerosis in subjects with type 2 diabetes mellitus.
    Pleskovič A; Letonja MŠ; Vujkovac AC; Nikolajević Starčević J; Gazdikova K; Caprnda M; Gaspar L; Kruzliak P; Petrovič D
    Vasa; 2017 May; 46(3):187-192. PubMed ID: 28218562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and prognosis in diabetes: getting to the heart of the matter.
    Sattar N; Hingorani AD
    Diabetes; 2009 Apr; 58(4):798-9. PubMed ID: 19336689
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictive value of some pro-oxidants in type 2 diabetes mellitus with vascular complications.
    Goycheva P; Nikolova G; Ivanova M; Kundurdzhiev T; Gadjeva V
    Biosci Trends; 2019 May; 13(2):168-175. PubMed ID: 30956269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings.
    Mugabo Y; Li L; Renier G
    Curr Diabetes Rev; 2010 Jan; 6(1):27-34. PubMed ID: 20034371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.
    Yu HI; Sheu WH; Song YM; Liu HC; Lee WJ; Chen YT
    Diabet Med; 2004 Apr; 21(4):336-41. PubMed ID: 15049935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline High-Sensitivity C-Reactive Protein Predicts Macrovascular and Microvascular Complications of Type 2 Diabetes: A Population-Based Study.
    Aryan Z; Ghajar A; Faghihi-Kashani S; Afarideh M; Nakhjavani M; Esteghamati A
    Ann Nutr Metab; 2018; 72(4):287-295. PubMed ID: 29694948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation analysis of epicardial adipose tissue thickness, C-reactive protein, interleukin-6, visfatin, juxtaposed with another zinc finger protein 1, and type 2 diabetic macroangiopathy.
    Gong YY; Peng HY
    Lipids Health Dis; 2021 Mar; 20(1):25. PubMed ID: 33722242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential impact and diagnostic value of inflammatory markers on diabetic foot progression in type II diabetes mellitus: A case-control study.
    Mohamed AA; Elmotaleb Hussein MA; Nabil Hanna I; Japer Nashwan AJ; Saleh M; Abdel Wahed WY; Mohamed Mansour AM; Ezz Al Arab MR; Fawzy N; Sakr Y; Shalby H; AlHussain E; Kamal Darwish M; El-Osaily H; Naguib M; Mohamed AA; Farouk Mohamed W; Hafez W
    Med Clin (Barc); 2024 May; 162(9):e33-e39. PubMed ID: 38458959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum myeloid-related protein 8/14 level is associated with atherosclerosis in type 2 diabetic patients.
    Peng WH; Jian WX; Li HL; Hou L; Wei YD; Li WM; Xu YW
    Cardiovasc Diabetol; 2011 May; 10():41. PubMed ID: 21592353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes.
    Hermans MP; Ahn SA; Rousseau MF
    J Diabetes Complications; 2019 Nov; 33(11):107413. PubMed ID: 31477553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoprotegerin and biomarkers of vascular inflammation in type 2 diabetes.
    O'Sullivan EP; Ashley DT; Davenport C; Devlin N; Crowley R; Agha A; Thompson CJ; O'Gorman D; Smith D
    Diabetes Metab Res Rev; 2010 Sep; 26(6):496-502. PubMed ID: 20809534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between levels of brain-derived neurotrophic factor and metabolic parameters in patients with type 2 diabetes mellitus.
    Boyuk B; Degirmencioglu S; Atalay H; Guzel S; Acar A; Celebi A; Ekizoglu I; Simsek C
    J Diabetes Res; 2014; 2014():978143. PubMed ID: 25587547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6.
    Fadaei R; Bagheri N; Heidarian E; Nouri A; Hesari Z; Moradi N; Ahmadi A; Ahmadi R
    Cytokine; 2020 Jan; 125():154832. PubMed ID: 31479874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein concentration predicts mortality in type 2 diabetes: the Diabetes Heart Study.
    Cox AJ; Agarwal S; M Herrington D; Carr JJ; Freedman BI; Bowden DW
    Diabet Med; 2012 Jun; 29(6):767-70. PubMed ID: 22211818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Synergic Association of hs-CRP and Serum Amyloid P Component in Predicting All-Cause Mortality in Patients With Type 2 Diabetes.
    Scarale MG; Copetti M; Garofolo M; Fontana A; Salvemini L; De Cosmo S; Lamacchia O; Penno G; Trischitta V; Menzaghi C
    Diabetes Care; 2020 May; 43(5):1025-1032. PubMed ID: 32144164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinopathy and hypertension affect serum high-sensitivity C-reactive protein levels in Type 2 diabetic patients.
    Tsunoda K; Arita M; Yukawa M; Ueyama M; Furuta M; Nakagawa T; Nanjo K; Sanke T
    J Diabetes Complications; 2005; 19(3):123-7. PubMed ID: 15866055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased concentration of C-reactive protein in obese patients with type 2 diabetes is associated with obesity and presence of diabetes but not with macrovascular and microvascular complications or glycemic control.
    Fronczyk A; Molęda P; Safranow K; Piechota W; Majkowska L
    Inflammation; 2014 Apr; 37(2):349-57. PubMed ID: 24197824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.